Immunology and Microbiology
Adoptive Immunotherapy
85%
Antineoplastic Activity
23%
Cancer Cell
38%
Cancer Immunotherapy
19%
CD28
28%
Cell Surface
19%
Chimeric Antigen Receptor
38%
Chimeric Antigen Receptor T-Cell
9%
Co-Stimulation
9%
Cytokine Release
23%
Germ Cell
9%
Immunological Memory
9%
Immunotherapy
9%
Integrin
19%
Interleukin 2
38%
Ligand Binding Domain
9%
Myeloid
19%
Myeloid-Derived Suppressor Cell
9%
Natural Killer Cell
28%
Preclinical Study
9%
Prostaglandin E
9%
Prostaglandin E2
9%
Regulatory T Cell
9%
Sensitization
19%
T Cell
76%
T-Cell Signaling
28%
Tumor Vascularization
9%
Tumor Volume
9%
Upregulation
9%
Medicine and Dentistry
Biogenesis
9%
Cancer
9%
Cancer Immunotherapy
28%
CD3 Antigen
14%
Cell Surface
9%
Chimeric Antigen Receptor
66%
Chimeric Antigen Receptor T-Cell
47%
Chimeric Antigen Receptor T-Cell Immunotherapy
28%
Chimeric Protein
9%
Clinical Stage
9%
Co-Stimulation
9%
Diseases
9%
ErbB
9%
Folate Receptor
9%
Hematologic Malignancy
14%
Human Leukocyte Antigen
9%
Immunosuppressive Drug
9%
Krukenberg Tumor
28%
Long Term Survival
9%
Malignant Neoplasm
19%
Mesothelin
9%
Natural Killer Cell Receptor NKG2D
9%
Neoplasm
33%
Ovarian Cancer
28%
Oxidative Phosphorylation
9%
Receptor
14%
Solid Malignant Neoplasm
47%
T Cell
47%
T-Cell Signaling
28%
Transcriptomics
9%
Tumor Antigen
9%
Xenograft
9%
Biochemistry, Genetics and Molecular Biology
Antineoplastic Activity
23%
Cancer Cell
19%
Cancer Immunotherapy
47%
CD28
28%
Chimeric Antigen Receptor
57%
Cytarabine
19%
Cytokine Release
23%
Integrin
19%
Interleukin 2
38%
Myeloid
19%
NKG2D
28%
Prostaglandin E
9%
Prostaglandin E2 Receptor
9%
Sensitization
19%
Signal Transduction
28%
T Cell
100%
